Published in PLoS One on December 02, 2014
Myasthenia gravis - autoantibody characteristics and their implications for therapy. Nat Rev Neurol (2016) 0.93
Precision medicine in myasthenia graves: begin from the data precision. Ann Transl Med (2016) 0.75
Blood Transcriptome Profiling in Myasthenia Gravis Patients to Assess Disease Activity: A Pilot RNA-seq Study. Exp Neurobiol (2016) 0.75
Understanding interobserver agreement: the kappa statistic. Fam Med (2005) 22.77
Sample size and optimal designs for reliability studies. Stat Med (1998) 6.80
Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med (2001) 3.26
Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. Lancet Neurol (2009) 2.86
Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays. J Neurol Neurosurg Psychiatry (1985) 2.11
Modulation of acetylcholine receptor by antibody against the receptor. Proc Natl Acad Sci U S A (1977) 2.04
Guidelines for treatment of autoimmune neuromuscular transmission disorders. Eur J Neurol (2010) 2.03
Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Ann Thorac Surg (2000) 1.99
Evidence of underdiagnosis of myasthenia gravis in older people. J Neurol Neurosurg Psychiatry (2003) 1.84
Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis. Ann Neurol (2011) 1.69
Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis. Arch Neurol (2011) 1.47
Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis. J Neurol (2011) 1.39
Extending half-life by indirect targeting of the neonatal Fc receptor (FcRn) using a minimal albumin binding domain. J Biol Chem (2010) 1.27
Myasthenia and the neuromuscular junction. Curr Opin Neurol (2012) 1.02
The myasthenic patient in crisis: an update of the management in Neurointensive Care Unit. Arq Neuropsiquiatr (2013) 0.97
Construction of an efficient evaluative instrument for myasthenia gravis: the MG composite. Muscle Nerve (2008) 0.97
Diagnostic use of autoantibodies in myasthenia gravis. Autoimmunity (2010) 0.95
Humoral pathogenesis of myasthenia gravis. Ann N Y Acad Sci (1987) 0.95
Myasthenia gravis requiring pyridostigmine treatment in a national population cohort. Eur J Neurol (2010) 0.93
Myasthenia gravis: a long term follow-up study of Swedish patients with specific reference to thymic histology. J Neurol Neurosurg Psychiatry (2007) 0.92
The membrane attack complex of complement at the endplate in myasthenia gravis. Ann N Y Acad Sci (1987) 0.91
Autoimmune mechanisms in myasthenia gravis. Curr Opin Neurol (2012) 0.90
Treatment of myasthenia gravis based on its immunopathogenesis. J Clin Neurol (2011) 0.90
The use of rituximab in myasthenia gravis and Lambert-Eaton myasthenic syndrome. J Neurol Neurosurg Psychiatry (2010) 0.88
Seropositive myasthenia gravis: a nationwide epidemiologic study. Neurology (2009) 0.88
Acetylcholine receptor-induced experimental myasthenia gravis: what have we learned from animal models after three decades? Arch Immunol Ther Exp (Warsz) (2011) 0.87
Antibodies identified by cell-based assays in myasthenia gravis and associated diseases. Ann N Y Acad Sci (2012) 0.86
Mechanisms associated with the pathogenicity of antibodies against muscle-specific kinase in myasthenia gravis. Autoimmun Rev (2013) 0.85
Myasthenic Crisis. Curr Treat Options Neurol (2004) 0.85
Complement associated pathogenic mechanisms in myasthenia gravis. Autoimmun Rev (2013) 0.83
Clinical aspects of myasthenia explained. Autoimmunity (2010) 0.81
Mechanism of block of nicotinic acetylcholine receptor channels by purified IgG from seropositive patients with myasthenia gravis. Neurology (2000) 0.81
Antibody specificity in myasthenia gravis. Monogr Allergy (1988) 0.78
Modified and improved anti-acetylcholine receptor (AchR) antibody assay: comparison of analytical and clinical performance with conventional anti-AChR antibody assay. Clin Chem (1997) 0.76
Depression and anxiety during pregnancy and the postpartum period in women with epilepsy: A review of frequency, risks and recommendations for treatment. Seizure (2015) 0.82
Spinal Cord Infarction in Clinical Neurology: A Review of Characteristics and Long-Term Prognosis in Comparison to Cerebral Infarction. Eur Neurol (2016) 0.81
Epilepsy and eating disorders during pregnancy: Prevalence, complications and birth outcome. Seizure (2015) 0.78
Autoantibody profile and clinical characteristics in a cohort of Chinese adult myasthenia gravis patients. J Neuroimmunol (2016) 0.77